mifepristone has been researched along with Fetal Death in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.13) | 18.7374 |
| 1990's | 8 (20.51) | 18.2507 |
| 2000's | 12 (30.77) | 29.6817 |
| 2010's | 11 (28.21) | 24.3611 |
| 2020's | 6 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Boucoiran, I; Ferreira, E; St-Pierre, ÉR; Vlad, S | 1 |
| Barker, E; Latta, K; Laursen, L; Testani, E; York, SL | 1 |
| Gudu, W; Shimeles, T; Sium, AF | 1 |
| Akter, S; Khan, KK; Mirza, N; Mirza, TT; Sarna, IZ; Shamsi, S; Sharmin, F | 1 |
| Cleeve, A; Fønhus, MS; Lavelanet, A | 1 |
| Bousieguez, M; Bracken, H; Ha, DQ; Linh, NTH; Ngoc, NTN; Ortiz, MA; Paredes, NR; Quyet, VB; Winikoff, B | 1 |
| Allanson, ER; Copson, S; Criddle, S; Dickinson, JE; Doherty, DA; Jennings, B; Spilsbury, K; Wong, AM | 1 |
| Fyfe, R; Murray, H | 1 |
| Atrio, J; Barnhart, KT; Creinin, MD; Ratcliffe, SJ; Schreiber, CA; Sonalkar, S | 1 |
| Hickey, M; Kim, BV; Lemmers, M; Mol, BWJ; Neilson, JP; Vazquez, JC; Verschoor, MA | 1 |
| Burke, A; Edelman, AB; Perritt, JB | 1 |
| Borgatta, L; Edelman, A; Mark, AG | 1 |
| Chaudhuri, P; Datta, S | 1 |
| Boulot, P; Cayrac, M; Faillie, JL; Flandrin, A | 1 |
| Faúndes, A | 1 |
| Paul, A; Sharma, D; Singhal, SR | 1 |
| de Weerd, S; Stibbe, KJ | 1 |
| Baton Saint-mleux, C; Bourget, P; Fernandez, H; Frydman, R; Lelaidier, C | 1 |
| Bernard, JP; Fischer, C; Senat, MV; Ville, Y | 1 |
| Bruinse, HW; Christiaens, GC; De Heus, R; Graziosi, GC; Mol, BW | 1 |
| Fairley, TE; Mackenzie, F; Mackenzie, M; Owen, P | 1 |
| Hickey, M; Neilson, JP; Vazquez, J | 1 |
| Creinin, MD; Harwood, BJ; Reeves, MF; Schreiber, CA | 1 |
| Heydanus, R; Papatsonis, DN; Verhulsdonk, MT | 1 |
| Heikinheimo, O; Nuutila, M; Väyrynen, W | 1 |
| Maria, B; Matheron, I | 1 |
| van Gend, D | 1 |
| Curry, M; Simpson, D | 1 |
| El-Refaey, H; Hoffman, L; le Roux, PA; Nooh, R; Pahal, GS; Rodeck, CH | 1 |
| Ashok, PW; Narvekar, N; Smith, NC; Templeton, A; Wagaarachchi, PT | 1 |
| Ashok, PW; Narvekar, NN; Smith, NC; Templeton, A; Wagaarachchi, PT | 1 |
| Ashok, PW; Smith, NC; Templeton, A; Wagaarachchi, PT | 1 |
| Arkaravichien, W; Kendle, KE | 1 |
| Fernandez, H; Frydman, R; Lelaidier, C; Pons, JC | 1 |
| Grall, F; Sylvestre, L | 1 |
| Jansen, RP | 1 |
| Cabrol, D; Cronje, H; Dubois, C; Gonnet, JM; Guillot, M; Maria, B; Moodley, J; Oury, JF; Thoulon, JM; Treisser, A | 1 |
| Heyns, A; Moodley, J; Norman, RJ; Padayachi, T | 1 |
| Baulieu, EE; Bouvier D'Yvoire, M; Cabrol, D; Cedard, L; Mermet, E; Sureau, C | 1 |
7 review(s) available for mifepristone and Fetal Death
| Article | Year |
|---|---|
A systematic review of the effectiveness, safety, and acceptability of medical management of intrauterine fetal death at 14-28 weeks of gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Dose-Response Relationship, Drug; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic | 2019 |
Medical treatment for early fetal death (less than 24 weeks).
Topics: Delivery, Obstetric; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Oxytocics; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic | 2019 |
Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods: release date June 2013 SFP guideline #20133.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Fetal Death; Gestational Age; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 2013 |
Second-trimester postabortion care for ruptured membranes, fetal demise, and incomplete abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Incomplete; Aftercare; Cohort Studies; Female; Fetal Death; Fetal Membranes, Premature Rupture; Humans; Mifepristone; Misoprostol; Oxytocics; Oxytocin; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic | 2015 |
Medical treatment for early fetal death (less than 24 weeks).
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Randomized Controlled Trials as Topic; Ultrasonography, Prenatal | 2006 |
[Methods of second trimester pregnancy termination and evacuation of in utero dead fetuses. Value of mifepristone].
Topics: Abortion, Induced; Clinical Protocols; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fetal Death; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Prostaglandins; Time Factors; Treatment Outcome | 1994 |
Unfinished feticide.
Topics: Abortion, Eugenic; Abortion, Induced; Abortion, Legal; Congenital Abnormalities; Ethics, Medical; Female; Fetal Death; France; Humans; Internationality; Liability, Legal; Malpractice; Mifepristone; Pregnancy; Pregnancy, Multiple | 1990 |
9 trial(s) available for mifepristone and Fetal Death
| Article | Year |
|---|---|
Mifepristone pretreatment followed by misoprostol 200 mcg buccal for the medical management of intrauterine fetal death at 14-28 weeks: A randomized, placebo-controlled, double blind trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Double-Blind Method; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Placenta; Pregnancy | 2020 |
Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Double-Blind Method; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Treatment Outcome; Young Adult | 2021 |
Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Administration, Intravaginal; Administration, Oral; Adult; Drug Therapy, Combination; Embryo, Mammalian; Female; Fetal Death; Gestational Sac; Hemorrhage; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Ultrasonography | 2018 |
Mifepristone and misoprostol compared with misoprostol alone for induction of labor in intrauterine fetal death: A randomized trial.
Topics: Adult; Double-Blind Method; Female; Fetal Death; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy | 2015 |
Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death: condensation - misoprostol and mifepristone combination is more effective than misoprostol alone in the management of intrauterine death
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Therapy, Combination; Female; Fetal Death; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Treatment Outcome; Young Adult | 2011 |
Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pilot Projects; Pregnancy; Treatment Outcome | 2006 |
[Use of mifepristone (RU 486) in pregnancy (excluding abortion on demand). The first clinical trials].
Topics: Abortion, Missed; Abortion, Therapeutic; Adult; Clinical Protocols; Female; Fetal Death; Humans; Mifepristone; Pregnancy; Treatment Outcome; Ultrasonography | 1991 |
Induction of labor with mifepristone (RU 486) in intrauterine fetal death.
Topics: Adult; Double-Blind Method; Drug Tolerance; Female; Fetal Death; Humans; Labor, Induced; Mifepristone; Multicenter Studies as Topic; Oxytocics; Pregnancy; Time Factors | 1990 |
Termination of pregnancy with mifepristone after intra-uterine death. Clinical and hormonal effects.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Adult; Chorionic Gonadotropin; Clinical Trials as Topic; Double-Blind Method; Estradiol; Estrenes; Female; Fetal Death; Humans; Hydrocortisone; Labor, Induced; Mifepristone; Pregnancy; Progesterone; Time Factors | 1989 |
23 other study(ies) available for mifepristone and Fetal Death
| Article | Year |
|---|---|
Mifepristone-Misoprostol Use for Second- and Third-Trimester Medical Termination of Pregnancy in a Canadian Tertiary Care Centre.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Canada; Cohort Studies; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Tertiary Care Centers | 2022 |
Complications of second-trimester medical termination of pregnancy for fetal anomalies compared with intrauterine fetal demise.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Fetal Death; Fetal Diseases; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Stillbirth | 2023 |
The effect of induced fetal demise on induction to expulsion interval during later medication abortion: A retrospective cohort.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Digoxin; Female; Fetal Death; Humans; Lidocaine; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2023 |
Role of Mifepristone in Trial of Labour after Previous Caesarean Delivery in Intrauterine Fetal Death.
Topics: Cesarean Section; Cross-Sectional Studies; Female; Fetal Death; Humans; Labor, Induced; Mifepristone; Pregnancy; Trial of Labor | 2023 |
Comparison of induction of labour regimes for termination of pregnancy, with and without mifepristone, from 20 to 41 weeks gestation.
Topics: Abortifacient Agents, Steroidal; Abortion, Eugenic; Adult; Female; Fetal Death; Gestational Age; Humans; Labor, Induced; Length of Stay; Mifepristone; Pregnancy; Retrospective Studies; Time Factors | 2017 |
Second- and third-trimester management of medical termination of pregnancy and fetal death in utero after prior caesarean section.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; Cesarean Section; Dose-Response Relationship, Drug; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Risk Factors; Time Factors; Uterine Rupture | 2011 |
The combination of mifepristone and misoprostol for the termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Therapy, Combination; Female; Fetal Death; Gestational Age; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy | 2011 |
Induction of delivery by mifepristone and misoprostol in termination of pregnancy and intrauterine fetal death: 2nd and 3rd trimester induction of labour.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Fetal Death; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third | 2012 |
[Inducing embryo expulsion in women with spontaneous fetal death in the first trimester. Use of mifepristone (RU-486) in a prospective, randomized, double blind study].
Topics: Abortion, Spontaneous; Biology; Demography; Developed Countries; Disease; Double-Blind Method; Endocrine System; Europe; Fetal Death; France; Hormone Antagonists; Hormones; Mifepristone; Mortality; Physiology; Population; Population Dynamics; Pregnancy Complications; Research | 1993 |
The use of lidocaine for fetocide in late termination of pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Amides; Analgesia, Patient-Controlled; Analgesics, Opioid; Anti-Arrhythmia Agents; Drug Combinations; Female; Fetal Death; Gestational Age; Heart Arrest; Humans; Injections, Intravenous; Lidocaine; Mifepristone; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Ropivacaine; Sufentanil; Umbilical Veins | 2003 |
Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
Topics: Abortifacient Agents; Abortion, Induced; Dinoprostone; Female; Fetal Death; Fetal Diseases; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Treatment Outcome | 2004 |
Management of late intrauterine death using a combination of mifepristone and misoprostol--experience of two regimens.
Topics: Abortifacient Agents; Delivery, Obstetric; Drug Therapy, Combination; Female; Fetal Death; Gestational Age; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy; Time Factors; Treatment Outcome | 2005 |
[Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Fetal Death; Fetal Diseases; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2007 |
Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adolescent; Adult; Drug Therapy, Combination; Female; Fetal Death; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Statistics, Nonparametric | 2007 |
Medical management of miscarriage with RU486.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Fetal Death; Humans; Mifepristone; Pregnancy | 1993 |
Supporting not punishing. A constructive approach to managing clinical errors.
Topics: Abortifacient Agents, Steroidal; Female; Fetal Death; Humans; Medication Errors; Mifepristone; Misoprostol; Nurse Midwives; Pregnancy; Risk Management | 2000 |
Second trimester termination of pregnancy for fetal anomaly or death: comparing mifepristone/misoprostol to gemeprost.
Topics: Abnormalities, Multiple; Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Intravaginal; Administration, Oral; Adult; Alprostadil; Female; Fetal Death; Humans; Maternal Age; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Reproductive History; Retrospective Studies; Treatment Outcome | 2001 |
Medical management of early fetal demise using a combination of mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adult; Curettage; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Uterine Hemorrhage | 2001 |
Medical management of late intrauterine death using a combination of mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adult; Drug Therapy, Combination; Female; Fetal Death; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Scotland; Sepsis; Ultrasonography | 2002 |
Medical management of early fetal demise using sublingual misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Adolescent; Adult; Drug Therapy, Combination; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Prospective Studies; Scotland | 2002 |
Fetal viability and fetal growth after prolonged uterine contractions induced by progesterone withdrawal in late pregnancy in rats.
Topics: Animals; Embryonic and Fetal Development; Female; Fetal Death; Fetal Viability; Gestational Age; Mifepristone; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Time Factors; Uterine Contraction | 1992 |
Mifepristone (RU 486) and vaginal induced abortion after two caesarean sections.
Topics: Abortion, Therapeutic; Adult; Female; Fetal Death; Humans; Meperidine; Mifepristone; Potassium Chloride; Pregnancy; Pregnancy Trimester, Second; Vaginal Birth after Cesarean | 1992 |
Induction of labour with mifepristone after intrauterine fetal death.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adult; Estrenes; Female; Fetal Death; Humans; Mifepristone; Pregnancy | 1985 |